Broad-spectrum anti-variant new coronavirus IgY, composite antibody, preparation method and combined preparation
A compound antigen and virus technology, applied in antiviral agents, viruses/bacteriophages, chemical instruments and methods, etc., can solve problems such as weakening of antibodies, discounting of drug efficacy, loss of neutralization effect, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0222] 2. Preparation of anti-mutant new coronavirus IgY
[0223] Considering the high mutational nature of the new coronavirus, even antibodies that can recognize conserved epitopes cannot recognize all mutant new coronaviruses. In particular, the mutation sites of the N501Y recently discovered in Europe and the dE484K recently discovered in South Africa are the key epitopes for the binding of the new coronavirus to human cells, which will greatly affect the actual effect of the previously developed antibody drugs. influences. Therefore, in order to completely solve the problem that the new coronavirus is easy to mutate and affect the curative effect, it is necessary to develop several corresponding anti-mutation new coronavirus IgYs for the mutations of key antigenic sites that are currently appearing. The present invention uses G614, N510K, and dE484K as examples to illustrate. Other new coronaviruses with key epitope mutations that will appear in the future can refer to t...
Embodiment 1
[0368] Example 1: Determination of the titer of broad-spectrum anti-mutant new coronavirus compound IgY neutralizing mutant new coronavirus by neutralization test
[0369] 1. Test material:
[0370] (1) Anti-broad-spectrum anti-mutation new coronavirus compound IgY: protein content 40mg / ml No. 1 specimen 1
[0371] (2) HRP enzyme-labeled rabbit anti-chicken IgG
[0372] (3) Negative antibody (IgY antibody of unimmunized eggs): 1 part of No. 2 specimen with protein content of 60mg / ml
[0373] (4) Positive control: 1 convalescent serum from a patient infected with the new coronavirus, specimen No. 3
[0374] (5) Negative control: 1 baby umbilical cord serum, specimen No. 4
[0375] (6) Viruses:
[0376] a. SARS-CoV-2 virus isolate I: Isolation and identification from throat test specimens of patients infected with SARS-CoV-2 virus.
[0377] b. SARS-CoV-2 virus isolate II: isolated and identified from serum samples of patients infected with SARS-CoV-2 virus.
[0378] (7) Ce...
Embodiment 2
[0392] Example 2: Production of broad-spectrum anti-mutation new coronavirus compound IgY atomizer for central air-conditioning, adding this atomizer to the water of central air-conditioning humidifier in a certain proportion, fully stirring evenly, and then mixing with air-conditioning after atomization The fresh air is mixed and sent into the room. , to achieve the effect of killing the new coronavirus that may exist in the indoor air.
[0393] formula:
[0394]
[0395] Process:
[0396] (1) Sterilize and sterilize the formula amount of pharmaceutical grade glycerin with ultraviolet light for 24 hours, and aseptically seal it for later use;
[0397] (2) Heat distilled water according to the formula to 90°C, keep it for 10 minutes, then cool to 60°C, then add pharmaceutical grade glycerin, stir at low speed for 60 minutes until fully dissolved; then, cool to room temperature to form solution A;
[0398] (3) While stirring, add the broad-spectrum anti-mutant new coronav...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com